Trial intelligence / Profile preview

CIST: Crystalloid vs Colloid + Crystalloid in Severe Trauma

NCT00890383Phase 4Completed

Sponsor
University of the Philippines
Start
May 2009
Primary completion
Nov 2009
Modality
Injectable Hydrogels, Implantable Hydrogels, Biodegradable Polymers
Countries
1
01

Overview

Phase 4, randomised, open-label trial of Volulyte in severe trauma and hemorrhagic shock (2 arms), sponsored by University of the Philippines. Primary endpoint: Intraabdominal hypertension at 30 days. Started May 2009; status: completed.

02

Drugs

Volulyte
03

Conditions

severe traumahemorrhagic shock

Beyond the preview

Go deeper on NCT00890383.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00890383.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call